Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses (2016 - 2025)

CorMedix (CRMD) has disclosed Other Accumulated Expenses for 11 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 1749.19% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 1749.19% year-over-year, with the annual reading at $2.3 million for FY2025, 1749.19% up from the prior year.
  • Other Accumulated Expenses hit $2.3 million in Q4 2025 for CorMedix, up from $278684.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q4 2025 to a low of $54763.0 in Q3 2023.
  • Historically, Other Accumulated Expenses has averaged $248060.2 across 5 years, with a median of $111260.0 in 2023.
  • Biggest YoY gain for Other Accumulated Expenses was 1749.19% in 2025; the steepest drop was 68.76% in 2025.
  • Year by year, Other Accumulated Expenses stood at $94736.0 in 2021, then tumbled by 31.96% to $64456.0 in 2022, then fell by 15.04% to $54763.0 in 2023, then skyrocketed by 126.43% to $124000.0 in 2024, then surged by 1749.19% to $2.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CRMD at $2.3 million in Q4 2025, $278684.0 in Q3 2025, and $136298.0 in Q2 2025.